1. Home
  2. WST vs AFRM Comparison

WST vs AFRM Comparison

Compare WST & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • AFRM
  • Stock Information
  • Founded
  • WST 1923
  • AFRM 2012
  • Country
  • WST United States
  • AFRM United States
  • Employees
  • WST N/A
  • AFRM N/A
  • Industry
  • WST Medical/Dental Instruments
  • AFRM Business Services
  • Sector
  • WST Health Care
  • AFRM Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • WST 20.1B
  • AFRM 21.3B
  • IPO Year
  • WST N/A
  • AFRM 2021
  • Fundamental
  • Price
  • WST $299.62
  • AFRM $76.02
  • Analyst Decision
  • WST Strong Buy
  • AFRM Buy
  • Analyst Count
  • WST 8
  • AFRM 26
  • Target Price
  • WST $348.00
  • AFRM $85.64
  • AVG Volume (30 Days)
  • WST 707.3K
  • AFRM 6.1M
  • Earning Date
  • WST 10-23-2025
  • AFRM 11-06-2025
  • Dividend Yield
  • WST 0.30%
  • AFRM N/A
  • EPS Growth
  • WST 0.17
  • AFRM N/A
  • EPS
  • WST 6.75
  • AFRM 0.15
  • Revenue
  • WST $3,017,900,000.00
  • AFRM $3,224,412,000.00
  • Revenue This Year
  • WST $6.49
  • AFRM $26.35
  • Revenue Next Year
  • WST $6.23
  • AFRM $23.86
  • P/E Ratio
  • WST $44.06
  • AFRM $470.45
  • Revenue Growth
  • WST 4.92
  • AFRM 38.80
  • 52 Week Low
  • WST $187.43
  • AFRM $30.90
  • 52 Week High
  • WST $352.33
  • AFRM $100.00
  • Technical
  • Relative Strength Index (RSI)
  • WST 72.87
  • AFRM 50.62
  • Support Level
  • WST $260.12
  • AFRM $69.97
  • Resistance Level
  • WST $322.34
  • AFRM $75.25
  • Average True Range (ATR)
  • WST 7.39
  • AFRM 3.92
  • MACD
  • WST 3.28
  • AFRM 0.45
  • Stochastic Oscillator
  • WST 64.97
  • AFRM 71.91

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: